Global Overactive Bladder (OAB) Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview:
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device.
The Global Overactive Bladder (OAB) Therapeutics Market Size was estimated at USD 5251.78 million in 2023 and is projected to reach USD 6054.89 million by 2029, exhibiting a CAGR of 2.40% during the forecast period.
This report provides a deep insight into the global Overactive Bladder (OAB) Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Overactive Bladder (OAB) Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Overactive Bladder (OAB) Therapeutics market in any manner.
Global Overactive Bladder (OAB) Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Allergan
Astellas Pharma
Hisamitsu Pharmaceutical
Pfizer
Ferring
GlaxoSmithKline
Ion Channel Innovations
Kwang Dong Pharmaceutical
Lanzhou Institute of Biological Products
Merck
ONO Pharmaceutical
Sanofi
Tengion
Teva Pharmaceutical Industries
Market Segmentation (by Type)
Anticholinergic Agents
Beta-3 Adrenoreceptor Agonists
Market Segmentation (by Application)
Hosptial
Clinci
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Overactive Bladder (OAB) Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device.
The Global Overactive Bladder (OAB) Therapeutics Market Size was estimated at USD 5251.78 million in 2023 and is projected to reach USD 6054.89 million by 2029, exhibiting a CAGR of 2.40% during the forecast period.
This report provides a deep insight into the global Overactive Bladder (OAB) Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Overactive Bladder (OAB) Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Overactive Bladder (OAB) Therapeutics market in any manner.
Global Overactive Bladder (OAB) Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Allergan
Astellas Pharma
Hisamitsu Pharmaceutical
Pfizer
Ferring
GlaxoSmithKline
Ion Channel Innovations
Kwang Dong Pharmaceutical
Lanzhou Institute of Biological Products
Merck
ONO Pharmaceutical
Sanofi
Tengion
Teva Pharmaceutical Industries
Market Segmentation (by Type)
Anticholinergic Agents
Beta-3 Adrenoreceptor Agonists
Market Segmentation (by Application)
Hosptial
Clinci
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Overactive Bladder (OAB) Therapeutics Market
- Overview of the regional outlook of the Overactive Bladder (OAB) Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Overactive Bladder (OAB) Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Overactive Bladder (OAB) Therapeutics
1.2 Key Market Segments
1.2.1 Overactive Bladder (OAB) Therapeutics Segment by Type
1.2.2 Overactive Bladder (OAB) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OVERACTIVE BLADDER (OAB) THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Overactive Bladder (OAB) Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Overactive Bladder (OAB) Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OVERACTIVE BLADDER (OAB) THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Overactive Bladder (OAB) Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Overactive Bladder (OAB) Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Overactive Bladder (OAB) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Overactive Bladder (OAB) Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Overactive Bladder (OAB) Therapeutics Sales Sites, Area Served, Product Type
3.6 Overactive Bladder (OAB) Therapeutics Market Competitive Situation and Trends
3.6.1 Overactive Bladder (OAB) Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Overactive Bladder (OAB) Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 OVERACTIVE BLADDER (OAB) THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Overactive Bladder (OAB) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OVERACTIVE BLADDER (OAB) THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 OVERACTIVE BLADDER (OAB) THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Overactive Bladder (OAB) Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Overactive Bladder (OAB) Therapeutics Price by Type (2019-2024)
7 OVERACTIVE BLADDER (OAB) THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Overactive Bladder (OAB) Therapeutics Market Sales by Application (2019-2024)
7.3 Global Overactive Bladder (OAB) Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Overactive Bladder (OAB) Therapeutics Sales Growth Rate by Application (2019-2024)
8 OVERACTIVE BLADDER (OAB) THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Overactive Bladder (OAB) Therapeutics Sales by Region
8.1.1 Global Overactive Bladder (OAB) Therapeutics Sales by Region
8.1.2 Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Overactive Bladder (OAB) Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Overactive Bladder (OAB) Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Overactive Bladder (OAB) Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Overactive Bladder (OAB) Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Allergan
9.1.1 Allergan Overactive Bladder (OAB) Therapeutics Basic Information
9.1.2 Allergan Overactive Bladder (OAB) Therapeutics Product Overview
9.1.3 Allergan Overactive Bladder (OAB) Therapeutics Product Market Performance
9.1.4 Allergan Business Overview
9.1.5 Allergan Overactive Bladder (OAB) Therapeutics SWOT Analysis
9.1.6 Allergan Recent Developments
9.2 Astellas Pharma
9.2.1 Astellas Pharma Overactive Bladder (OAB) Therapeutics Basic Information
9.2.2 Astellas Pharma Overactive Bladder (OAB) Therapeutics Product Overview
9.2.3 Astellas Pharma Overactive Bladder (OAB) Therapeutics Product Market Performance
9.2.4 Astellas Pharma Business Overview
9.2.5 Astellas Pharma Overactive Bladder (OAB) Therapeutics SWOT Analysis
9.2.6 Astellas Pharma Recent Developments
9.3 Hisamitsu Pharmaceutical
9.3.1 Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Basic Information
9.3.2 Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Overview
9.3.3 Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Market Performance
9.3.4 Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics SWOT Analysis
9.3.5 Hisamitsu Pharmaceutical Business Overview
9.3.6 Hisamitsu Pharmaceutical Recent Developments
9.4 Pfizer
9.4.1 Pfizer Overactive Bladder (OAB) Therapeutics Basic Information
9.4.2 Pfizer Overactive Bladder (OAB) Therapeutics Product Overview
9.4.3 Pfizer Overactive Bladder (OAB) Therapeutics Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Recent Developments
9.5 Ferring
9.5.1 Ferring Overactive Bladder (OAB) Therapeutics Basic Information
9.5.2 Ferring Overactive Bladder (OAB) Therapeutics Product Overview
9.5.3 Ferring Overactive Bladder (OAB) Therapeutics Product Market Performance
9.5.4 Ferring Business Overview
9.5.5 Ferring Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Basic Information
9.6.2 GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Product Overview
9.6.3 GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
9.7 Ion Channel Innovations
9.7.1 Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Basic Information
9.7.2 Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Product Overview
9.7.3 Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Product Market Performance
9.7.4 Ion Channel Innovations Business Overview
9.7.5 Ion Channel Innovations Recent Developments
9.8 Kwang Dong Pharmaceutical
9.8.1 Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Basic Information
9.8.2 Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Overview
9.8.3 Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Market Performance
9.8.4 Kwang Dong Pharmaceutical Business Overview
9.8.5 Kwang Dong Pharmaceutical Recent Developments
9.9 Lanzhou Institute of Biological Products
9.9.1 Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Basic Information
9.9.2 Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Product Overview
9.9.3 Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Product Market Performance
9.9.4 Lanzhou Institute of Biological Products Business Overview
9.9.5 Lanzhou Institute of Biological Products Recent Developments
9.10 Merck
9.10.1 Merck Overactive Bladder (OAB) Therapeutics Basic Information
9.10.2 Merck Overactive Bladder (OAB) Therapeutics Product Overview
9.10.3 Merck Overactive Bladder (OAB) Therapeutics Product Market Performance
9.10.4 Merck Business Overview
9.10.5 Merck Recent Developments
9.11 ONO Pharmaceutical
9.11.1 ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Basic Information
9.11.2 ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Overview
9.11.3 ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Market Performance
9.11.4 ONO Pharmaceutical Business Overview
9.11.5 ONO Pharmaceutical Recent Developments
9.12 Sanofi
9.12.1 Sanofi Overactive Bladder (OAB) Therapeutics Basic Information
9.12.2 Sanofi Overactive Bladder (OAB) Therapeutics Product Overview
9.12.3 Sanofi Overactive Bladder (OAB) Therapeutics Product Market Performance
9.12.4 Sanofi Business Overview
9.12.5 Sanofi Recent Developments
9.13 Tengion
9.13.1 Tengion Overactive Bladder (OAB) Therapeutics Basic Information
9.13.2 Tengion Overactive Bladder (OAB) Therapeutics Product Overview
9.13.3 Tengion Overactive Bladder (OAB) Therapeutics Product Market Performance
9.13.4 Tengion Business Overview
9.13.5 Tengion Recent Developments
9.14 Teva Pharmaceutical Industries
9.14.1 Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Basic Information
9.14.2 Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Product Overview
9.14.3 Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Product Market Performance
9.14.4 Teva Pharmaceutical Industries Business Overview
9.14.5 Teva Pharmaceutical Industries Recent Developments
10 OVERACTIVE BLADDER (OAB) THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Overactive Bladder (OAB) Therapeutics Market Size Forecast
10.2 Global Overactive Bladder (OAB) Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Overactive Bladder (OAB) Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Overactive Bladder (OAB) Therapeutics Market Size Forecast by Region
10.2.4 South America Overactive Bladder (OAB) Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Overactive Bladder (OAB) Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Overactive Bladder (OAB) Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Overactive Bladder (OAB) Therapeutics by Type (2025-2030)
11.1.2 Global Overactive Bladder (OAB) Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Overactive Bladder (OAB) Therapeutics by Type (2025-2030)
11.2 Global Overactive Bladder (OAB) Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Overactive Bladder (OAB) Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global Overactive Bladder (OAB) Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Overactive Bladder (OAB) Therapeutics
1.2 Key Market Segments
1.2.1 Overactive Bladder (OAB) Therapeutics Segment by Type
1.2.2 Overactive Bladder (OAB) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OVERACTIVE BLADDER (OAB) THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Overactive Bladder (OAB) Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Overactive Bladder (OAB) Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OVERACTIVE BLADDER (OAB) THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Overactive Bladder (OAB) Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Overactive Bladder (OAB) Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Overactive Bladder (OAB) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Overactive Bladder (OAB) Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Overactive Bladder (OAB) Therapeutics Sales Sites, Area Served, Product Type
3.6 Overactive Bladder (OAB) Therapeutics Market Competitive Situation and Trends
3.6.1 Overactive Bladder (OAB) Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Overactive Bladder (OAB) Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 OVERACTIVE BLADDER (OAB) THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Overactive Bladder (OAB) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OVERACTIVE BLADDER (OAB) THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 OVERACTIVE BLADDER (OAB) THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Overactive Bladder (OAB) Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Overactive Bladder (OAB) Therapeutics Price by Type (2019-2024)
7 OVERACTIVE BLADDER (OAB) THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Overactive Bladder (OAB) Therapeutics Market Sales by Application (2019-2024)
7.3 Global Overactive Bladder (OAB) Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Overactive Bladder (OAB) Therapeutics Sales Growth Rate by Application (2019-2024)
8 OVERACTIVE BLADDER (OAB) THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Overactive Bladder (OAB) Therapeutics Sales by Region
8.1.1 Global Overactive Bladder (OAB) Therapeutics Sales by Region
8.1.2 Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Overactive Bladder (OAB) Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Overactive Bladder (OAB) Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Overactive Bladder (OAB) Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Overactive Bladder (OAB) Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Allergan
9.1.1 Allergan Overactive Bladder (OAB) Therapeutics Basic Information
9.1.2 Allergan Overactive Bladder (OAB) Therapeutics Product Overview
9.1.3 Allergan Overactive Bladder (OAB) Therapeutics Product Market Performance
9.1.4 Allergan Business Overview
9.1.5 Allergan Overactive Bladder (OAB) Therapeutics SWOT Analysis
9.1.6 Allergan Recent Developments
9.2 Astellas Pharma
9.2.1 Astellas Pharma Overactive Bladder (OAB) Therapeutics Basic Information
9.2.2 Astellas Pharma Overactive Bladder (OAB) Therapeutics Product Overview
9.2.3 Astellas Pharma Overactive Bladder (OAB) Therapeutics Product Market Performance
9.2.4 Astellas Pharma Business Overview
9.2.5 Astellas Pharma Overactive Bladder (OAB) Therapeutics SWOT Analysis
9.2.6 Astellas Pharma Recent Developments
9.3 Hisamitsu Pharmaceutical
9.3.1 Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Basic Information
9.3.2 Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Overview
9.3.3 Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Market Performance
9.3.4 Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics SWOT Analysis
9.3.5 Hisamitsu Pharmaceutical Business Overview
9.3.6 Hisamitsu Pharmaceutical Recent Developments
9.4 Pfizer
9.4.1 Pfizer Overactive Bladder (OAB) Therapeutics Basic Information
9.4.2 Pfizer Overactive Bladder (OAB) Therapeutics Product Overview
9.4.3 Pfizer Overactive Bladder (OAB) Therapeutics Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Recent Developments
9.5 Ferring
9.5.1 Ferring Overactive Bladder (OAB) Therapeutics Basic Information
9.5.2 Ferring Overactive Bladder (OAB) Therapeutics Product Overview
9.5.3 Ferring Overactive Bladder (OAB) Therapeutics Product Market Performance
9.5.4 Ferring Business Overview
9.5.5 Ferring Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Basic Information
9.6.2 GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Product Overview
9.6.3 GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
9.7 Ion Channel Innovations
9.7.1 Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Basic Information
9.7.2 Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Product Overview
9.7.3 Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Product Market Performance
9.7.4 Ion Channel Innovations Business Overview
9.7.5 Ion Channel Innovations Recent Developments
9.8 Kwang Dong Pharmaceutical
9.8.1 Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Basic Information
9.8.2 Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Overview
9.8.3 Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Market Performance
9.8.4 Kwang Dong Pharmaceutical Business Overview
9.8.5 Kwang Dong Pharmaceutical Recent Developments
9.9 Lanzhou Institute of Biological Products
9.9.1 Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Basic Information
9.9.2 Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Product Overview
9.9.3 Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Product Market Performance
9.9.4 Lanzhou Institute of Biological Products Business Overview
9.9.5 Lanzhou Institute of Biological Products Recent Developments
9.10 Merck
9.10.1 Merck Overactive Bladder (OAB) Therapeutics Basic Information
9.10.2 Merck Overactive Bladder (OAB) Therapeutics Product Overview
9.10.3 Merck Overactive Bladder (OAB) Therapeutics Product Market Performance
9.10.4 Merck Business Overview
9.10.5 Merck Recent Developments
9.11 ONO Pharmaceutical
9.11.1 ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Basic Information
9.11.2 ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Overview
9.11.3 ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Market Performance
9.11.4 ONO Pharmaceutical Business Overview
9.11.5 ONO Pharmaceutical Recent Developments
9.12 Sanofi
9.12.1 Sanofi Overactive Bladder (OAB) Therapeutics Basic Information
9.12.2 Sanofi Overactive Bladder (OAB) Therapeutics Product Overview
9.12.3 Sanofi Overactive Bladder (OAB) Therapeutics Product Market Performance
9.12.4 Sanofi Business Overview
9.12.5 Sanofi Recent Developments
9.13 Tengion
9.13.1 Tengion Overactive Bladder (OAB) Therapeutics Basic Information
9.13.2 Tengion Overactive Bladder (OAB) Therapeutics Product Overview
9.13.3 Tengion Overactive Bladder (OAB) Therapeutics Product Market Performance
9.13.4 Tengion Business Overview
9.13.5 Tengion Recent Developments
9.14 Teva Pharmaceutical Industries
9.14.1 Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Basic Information
9.14.2 Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Product Overview
9.14.3 Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Product Market Performance
9.14.4 Teva Pharmaceutical Industries Business Overview
9.14.5 Teva Pharmaceutical Industries Recent Developments
10 OVERACTIVE BLADDER (OAB) THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Overactive Bladder (OAB) Therapeutics Market Size Forecast
10.2 Global Overactive Bladder (OAB) Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Overactive Bladder (OAB) Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Overactive Bladder (OAB) Therapeutics Market Size Forecast by Region
10.2.4 South America Overactive Bladder (OAB) Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Overactive Bladder (OAB) Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Overactive Bladder (OAB) Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Overactive Bladder (OAB) Therapeutics by Type (2025-2030)
11.1.2 Global Overactive Bladder (OAB) Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Overactive Bladder (OAB) Therapeutics by Type (2025-2030)
11.2 Global Overactive Bladder (OAB) Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Overactive Bladder (OAB) Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global Overactive Bladder (OAB) Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Overactive Bladder (OAB) Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Overactive Bladder (OAB) Therapeutics Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Overactive Bladder (OAB) Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Overactive Bladder (OAB) Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overactive Bladder (OAB) Therapeutics as of 2022)
Table 10. Global Market Overactive Bladder (OAB) Therapeutics Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Overactive Bladder (OAB) Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Overactive Bladder (OAB) Therapeutics Product Type
Table 13. Global Overactive Bladder (OAB) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Overactive Bladder (OAB) Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Overactive Bladder (OAB) Therapeutics Market Challenges
Table 22. Global Overactive Bladder (OAB) Therapeutics Sales by Type (Kilotons)
Table 23. Global Overactive Bladder (OAB) Therapeutics Market Size by Type (M USD)
Table 24. Global Overactive Bladder (OAB) Therapeutics Sales (Kilotons) by Type (2019-2024)
Table 25. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Overactive Bladder (OAB) Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Overactive Bladder (OAB) Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Overactive Bladder (OAB) Therapeutics Price (USD/Ton) by Type (2019-2024)
Table 29. Global Overactive Bladder (OAB) Therapeutics Sales (Kilotons) by Application
Table 30. Global Overactive Bladder (OAB) Therapeutics Market Size by Application
Table 31. Global Overactive Bladder (OAB) Therapeutics Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Overactive Bladder (OAB) Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Overactive Bladder (OAB) Therapeutics Market Share by Application (2019-2024)
Table 35. Global Overactive Bladder (OAB) Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Overactive Bladder (OAB) Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Overactive Bladder (OAB) Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Overactive Bladder (OAB) Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Overactive Bladder (OAB) Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Overactive Bladder (OAB) Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 43. Allergan Overactive Bladder (OAB) Therapeutics Basic Information
Table 44. Allergan Overactive Bladder (OAB) Therapeutics Product Overview
Table 45. Allergan Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Allergan Business Overview
Table 47. Allergan Overactive Bladder (OAB) Therapeutics SWOT Analysis
Table 48. Allergan Recent Developments
Table 49. Astellas Pharma Overactive Bladder (OAB) Therapeutics Basic Information
Table 50. Astellas Pharma Overactive Bladder (OAB) Therapeutics Product Overview
Table 51. Astellas Pharma Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Astellas Pharma Business Overview
Table 53. Astellas Pharma Overactive Bladder (OAB) Therapeutics SWOT Analysis
Table 54. Astellas Pharma Recent Developments
Table 55. Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Basic Information
Table 56. Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Overview
Table 57. Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics SWOT Analysis
Table 59. Hisamitsu Pharmaceutical Business Overview
Table 60. Hisamitsu Pharmaceutical Recent Developments
Table 61. Pfizer Overactive Bladder (OAB) Therapeutics Basic Information
Table 62. Pfizer Overactive Bladder (OAB) Therapeutics Product Overview
Table 63. Pfizer Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Pfizer Business Overview
Table 65. Pfizer Recent Developments
Table 66. Ferring Overactive Bladder (OAB) Therapeutics Basic Information
Table 67. Ferring Overactive Bladder (OAB) Therapeutics Product Overview
Table 68. Ferring Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Ferring Business Overview
Table 70. Ferring Recent Developments
Table 71. GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Basic Information
Table 72. GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Product Overview
Table 73. GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Recent Developments
Table 76. Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Basic Information
Table 77. Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Product Overview
Table 78. Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Ion Channel Innovations Business Overview
Table 80. Ion Channel Innovations Recent Developments
Table 81. Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Basic Information
Table 82. Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Overview
Table 83. Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Kwang Dong Pharmaceutical Business Overview
Table 85. Kwang Dong Pharmaceutical Recent Developments
Table 86. Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Basic Information
Table 87. Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Product Overview
Table 88. Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Lanzhou Institute of Biological Products Business Overview
Table 90. Lanzhou Institute of Biological Products Recent Developments
Table 91. Merck Overactive Bladder (OAB) Therapeutics Basic Information
Table 92. Merck Overactive Bladder (OAB) Therapeutics Product Overview
Table 93. Merck Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Merck Business Overview
Table 95. Merck Recent Developments
Table 96. ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Basic Information
Table 97. ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Overview
Table 98. ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. ONO Pharmaceutical Business Overview
Table 100. ONO Pharmaceutical Recent Developments
Table 101. Sanofi Overactive Bladder (OAB) Therapeutics Basic Information
Table 102. Sanofi Overactive Bladder (OAB) Therapeutics Product Overview
Table 103. Sanofi Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Sanofi Business Overview
Table 105. Sanofi Recent Developments
Table 106. Tengion Overactive Bladder (OAB) Therapeutics Basic Information
Table 107. Tengion Overactive Bladder (OAB) Therapeutics Product Overview
Table 108. Tengion Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Tengion Business Overview
Table 110. Tengion Recent Developments
Table 111. Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Basic Information
Table 112. Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Product Overview
Table 113. Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Teva Pharmaceutical Industries Business Overview
Table 115. Teva Pharmaceutical Industries Recent Developments
Table 116. Global Overactive Bladder (OAB) Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 117. Global Overactive Bladder (OAB) Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Overactive Bladder (OAB) Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 119. North America Overactive Bladder (OAB) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Overactive Bladder (OAB) Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 121. Europe Overactive Bladder (OAB) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Overactive Bladder (OAB) Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 123. Asia Pacific Overactive Bladder (OAB) Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Overactive Bladder (OAB) Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 125. South America Overactive Bladder (OAB) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Overactive Bladder (OAB) Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Overactive Bladder (OAB) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Overactive Bladder (OAB) Therapeutics Sales Forecast by Type (2025-2030) & (Kilotons)
Table 129. Global Overactive Bladder (OAB) Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Overactive Bladder (OAB) Therapeutics Price Forecast by Type (2025-2030) & (USD/Ton)
Table 131. Global Overactive Bladder (OAB) Therapeutics Sales (Kilotons) Forecast by Application (2025-2030)
Table 132. Global Overactive Bladder (OAB) Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Overactive Bladder (OAB) Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Overactive Bladder (OAB) Therapeutics Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Overactive Bladder (OAB) Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Overactive Bladder (OAB) Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Overactive Bladder (OAB) Therapeutics as of 2022)
Table 10. Global Market Overactive Bladder (OAB) Therapeutics Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Overactive Bladder (OAB) Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Overactive Bladder (OAB) Therapeutics Product Type
Table 13. Global Overactive Bladder (OAB) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Overactive Bladder (OAB) Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Overactive Bladder (OAB) Therapeutics Market Challenges
Table 22. Global Overactive Bladder (OAB) Therapeutics Sales by Type (Kilotons)
Table 23. Global Overactive Bladder (OAB) Therapeutics Market Size by Type (M USD)
Table 24. Global Overactive Bladder (OAB) Therapeutics Sales (Kilotons) by Type (2019-2024)
Table 25. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Overactive Bladder (OAB) Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Overactive Bladder (OAB) Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Overactive Bladder (OAB) Therapeutics Price (USD/Ton) by Type (2019-2024)
Table 29. Global Overactive Bladder (OAB) Therapeutics Sales (Kilotons) by Application
Table 30. Global Overactive Bladder (OAB) Therapeutics Market Size by Application
Table 31. Global Overactive Bladder (OAB) Therapeutics Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Overactive Bladder (OAB) Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Overactive Bladder (OAB) Therapeutics Market Share by Application (2019-2024)
Table 35. Global Overactive Bladder (OAB) Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Overactive Bladder (OAB) Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Overactive Bladder (OAB) Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Overactive Bladder (OAB) Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Overactive Bladder (OAB) Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Overactive Bladder (OAB) Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 43. Allergan Overactive Bladder (OAB) Therapeutics Basic Information
Table 44. Allergan Overactive Bladder (OAB) Therapeutics Product Overview
Table 45. Allergan Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Allergan Business Overview
Table 47. Allergan Overactive Bladder (OAB) Therapeutics SWOT Analysis
Table 48. Allergan Recent Developments
Table 49. Astellas Pharma Overactive Bladder (OAB) Therapeutics Basic Information
Table 50. Astellas Pharma Overactive Bladder (OAB) Therapeutics Product Overview
Table 51. Astellas Pharma Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Astellas Pharma Business Overview
Table 53. Astellas Pharma Overactive Bladder (OAB) Therapeutics SWOT Analysis
Table 54. Astellas Pharma Recent Developments
Table 55. Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Basic Information
Table 56. Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Overview
Table 57. Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Hisamitsu Pharmaceutical Overactive Bladder (OAB) Therapeutics SWOT Analysis
Table 59. Hisamitsu Pharmaceutical Business Overview
Table 60. Hisamitsu Pharmaceutical Recent Developments
Table 61. Pfizer Overactive Bladder (OAB) Therapeutics Basic Information
Table 62. Pfizer Overactive Bladder (OAB) Therapeutics Product Overview
Table 63. Pfizer Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Pfizer Business Overview
Table 65. Pfizer Recent Developments
Table 66. Ferring Overactive Bladder (OAB) Therapeutics Basic Information
Table 67. Ferring Overactive Bladder (OAB) Therapeutics Product Overview
Table 68. Ferring Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Ferring Business Overview
Table 70. Ferring Recent Developments
Table 71. GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Basic Information
Table 72. GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Product Overview
Table 73. GlaxoSmithKline Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Recent Developments
Table 76. Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Basic Information
Table 77. Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Product Overview
Table 78. Ion Channel Innovations Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Ion Channel Innovations Business Overview
Table 80. Ion Channel Innovations Recent Developments
Table 81. Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Basic Information
Table 82. Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Overview
Table 83. Kwang Dong Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Kwang Dong Pharmaceutical Business Overview
Table 85. Kwang Dong Pharmaceutical Recent Developments
Table 86. Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Basic Information
Table 87. Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Product Overview
Table 88. Lanzhou Institute of Biological Products Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Lanzhou Institute of Biological Products Business Overview
Table 90. Lanzhou Institute of Biological Products Recent Developments
Table 91. Merck Overactive Bladder (OAB) Therapeutics Basic Information
Table 92. Merck Overactive Bladder (OAB) Therapeutics Product Overview
Table 93. Merck Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Merck Business Overview
Table 95. Merck Recent Developments
Table 96. ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Basic Information
Table 97. ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Product Overview
Table 98. ONO Pharmaceutical Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. ONO Pharmaceutical Business Overview
Table 100. ONO Pharmaceutical Recent Developments
Table 101. Sanofi Overactive Bladder (OAB) Therapeutics Basic Information
Table 102. Sanofi Overactive Bladder (OAB) Therapeutics Product Overview
Table 103. Sanofi Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Sanofi Business Overview
Table 105. Sanofi Recent Developments
Table 106. Tengion Overactive Bladder (OAB) Therapeutics Basic Information
Table 107. Tengion Overactive Bladder (OAB) Therapeutics Product Overview
Table 108. Tengion Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Tengion Business Overview
Table 110. Tengion Recent Developments
Table 111. Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Basic Information
Table 112. Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Product Overview
Table 113. Teva Pharmaceutical Industries Overactive Bladder (OAB) Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Teva Pharmaceutical Industries Business Overview
Table 115. Teva Pharmaceutical Industries Recent Developments
Table 116. Global Overactive Bladder (OAB) Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 117. Global Overactive Bladder (OAB) Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Overactive Bladder (OAB) Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 119. North America Overactive Bladder (OAB) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Overactive Bladder (OAB) Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 121. Europe Overactive Bladder (OAB) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Overactive Bladder (OAB) Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 123. Asia Pacific Overactive Bladder (OAB) Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Overactive Bladder (OAB) Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 125. South America Overactive Bladder (OAB) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Overactive Bladder (OAB) Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Overactive Bladder (OAB) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Overactive Bladder (OAB) Therapeutics Sales Forecast by Type (2025-2030) & (Kilotons)
Table 129. Global Overactive Bladder (OAB) Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Overactive Bladder (OAB) Therapeutics Price Forecast by Type (2025-2030) & (USD/Ton)
Table 131. Global Overactive Bladder (OAB) Therapeutics Sales (Kilotons) Forecast by Application (2025-2030)
Table 132. Global Overactive Bladder (OAB) Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Overactive Bladder (OAB) Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Overactive Bladder (OAB) Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Overactive Bladder (OAB) Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Overactive Bladder (OAB) Therapeutics Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Overactive Bladder (OAB) Therapeutics Market Size by Country (M USD)
Figure 11. Overactive Bladder (OAB) Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Overactive Bladder (OAB) Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Overactive Bladder (OAB) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Overactive Bladder (OAB) Therapeutics Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Overactive Bladder (OAB) Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Overactive Bladder (OAB) Therapeutics Market Share by Type
Figure 18. Sales Market Share of Overactive Bladder (OAB) Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Overactive Bladder (OAB) Therapeutics by Type in 2023
Figure 20. Market Size Share of Overactive Bladder (OAB) Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Overactive Bladder (OAB) Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Overactive Bladder (OAB) Therapeutics Market Share by Application
Figure 24. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Overactive Bladder (OAB) Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Overactive Bladder (OAB) Therapeutics Market Share by Application in 2023
Figure 28. Global Overactive Bladder (OAB) Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Overactive Bladder (OAB) Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Overactive Bladder (OAB) Therapeutics Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Overactive Bladder (OAB) Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Overactive Bladder (OAB) Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Overactive Bladder (OAB) Therapeutics Sales Market Share by Region in 2023
Figure 44. China Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (Kilotons)
Figure 50. South America Overactive Bladder (OAB) Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Overactive Bladder (OAB) Therapeutics Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Overactive Bladder (OAB) Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Overactive Bladder (OAB) Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Overactive Bladder (OAB) Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Overactive Bladder (OAB) Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Overactive Bladder (OAB) Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Overactive Bladder (OAB) Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Overactive Bladder (OAB) Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Overactive Bladder (OAB) Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Overactive Bladder (OAB) Therapeutics Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Overactive Bladder (OAB) Therapeutics Market Size by Country (M USD)
Figure 11. Overactive Bladder (OAB) Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Overactive Bladder (OAB) Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Overactive Bladder (OAB) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Overactive Bladder (OAB) Therapeutics Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Overactive Bladder (OAB) Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Overactive Bladder (OAB) Therapeutics Market Share by Type
Figure 18. Sales Market Share of Overactive Bladder (OAB) Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Overactive Bladder (OAB) Therapeutics by Type in 2023
Figure 20. Market Size Share of Overactive Bladder (OAB) Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Overactive Bladder (OAB) Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Overactive Bladder (OAB) Therapeutics Market Share by Application
Figure 24. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Overactive Bladder (OAB) Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Overactive Bladder (OAB) Therapeutics Market Share by Application in 2023
Figure 28. Global Overactive Bladder (OAB) Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Overactive Bladder (OAB) Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Overactive Bladder (OAB) Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Overactive Bladder (OAB) Therapeutics Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Overactive Bladder (OAB) Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Overactive Bladder (OAB) Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Overactive Bladder (OAB) Therapeutics Sales Market Share by Region in 2023
Figure 44. China Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (Kilotons)
Figure 50. South America Overactive Bladder (OAB) Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Overactive Bladder (OAB) Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Overactive Bladder (OAB) Therapeutics Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Overactive Bladder (OAB) Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Overactive Bladder (OAB) Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Overactive Bladder (OAB) Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Overactive Bladder (OAB) Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Overactive Bladder (OAB) Therapeutics Market Share Forecast by Application (2025-2030)
